TY - JOUR
T1 - Prevalence of acute coronary syndrome during the pandemic of COVID-19 in the Tokai Region of Japan
AU - Kudo, Nobutaka
AU - Tanaka, Akihito
AU - Ishii, Hideki
AU - Uemura, Yusuke
AU - Takagi, Kensuke
AU - Iwama, Makoto
AU - Yoshida, Ruka
AU - Ohashi, Taiki
AU - Kawai, Hideki
AU - Negishi, Yosuke
AU - Umemoto, Norio
AU - Tanaka, Miho
AU - Watarai, Masato
AU - Yoshioka, Naoki
AU - Morishima, Itsuro
AU - Noda, Toshiyuki
AU - Yoshida, Yukihiko
AU - Tatami, Yosuke
AU - Muramatsu, Takashi
AU - Tanaka, Toshikazu
AU - Tashiro, Hiroshi
AU - Takada, Yasunobu
AU - Izawa, Hideo
AU - Watanabe, Eiichi
AU - Murohara, Toyoaki
N1 - Publisher Copyright:
© 2021. Nagoya Journal of Medical Science. All Rights Reserved.
PY - 2021
Y1 - 2021
N2 - The outbreak of coronavirus disease 19 (COVID-19) has had a great impact on medical care. During the COVID-19 pandemic, the rate of hospital admissions has been lower and the rate of in-hospital mortality has been higher in patients with acute coronary syndrome (ACS) in Western countries. However, in Japan, it is unknown whether the COVID-19 pandemic has affected the incidence of ACS. In the study, eleven hospitals in the Tokai region participated. Among enrolled hospital, we compared the incidence of ACS during the COVID-19 pandemic (April and May, 2020) with that in equivalent months in the preceding year as the control. During the study period; April and May 2020, 248 patients with ACS were admitted. Compared to April and May 2019, a decline of 8.1% [95% confidence interval (CI) 5.2–12.1; P = 0.33] in admissions for ACS was observed between April and May 2020. There was no significant difference in the strategy for revascularization and in-hospital deaths between 2019 and 2020. In conclusion, the rate of admission for ACS slightly decreased during the COVID-19 pandemic, compared to the same months in the preceding year. Moreover, degeneration of therapeutic procedures for ACS did not occur.
AB - The outbreak of coronavirus disease 19 (COVID-19) has had a great impact on medical care. During the COVID-19 pandemic, the rate of hospital admissions has been lower and the rate of in-hospital mortality has been higher in patients with acute coronary syndrome (ACS) in Western countries. However, in Japan, it is unknown whether the COVID-19 pandemic has affected the incidence of ACS. In the study, eleven hospitals in the Tokai region participated. Among enrolled hospital, we compared the incidence of ACS during the COVID-19 pandemic (April and May, 2020) with that in equivalent months in the preceding year as the control. During the study period; April and May 2020, 248 patients with ACS were admitted. Compared to April and May 2019, a decline of 8.1% [95% confidence interval (CI) 5.2–12.1; P = 0.33] in admissions for ACS was observed between April and May 2020. There was no significant difference in the strategy for revascularization and in-hospital deaths between 2019 and 2020. In conclusion, the rate of admission for ACS slightly decreased during the COVID-19 pandemic, compared to the same months in the preceding year. Moreover, degeneration of therapeutic procedures for ACS did not occur.
UR - https://www.scopus.com/pages/publications/85120969319
UR - https://www.scopus.com/pages/publications/85120969319#tab=citedBy
U2 - 10.18999/nagjms.83.4.697
DO - 10.18999/nagjms.83.4.697
M3 - Article
C2 - 34916714
AN - SCOPUS:85120969319
SN - 0027-7622
VL - 83
SP - 697
EP - 703
JO - Nagoya journal of medical science
JF - Nagoya journal of medical science
IS - 4
ER -